Wegovy (semaglutide) is a GLP-1 receptor agonist weight loss medication approved by the U.S
Confirm that consultation fees become non-refundable after provider review, even if prescribing is declined
Continuous Support and Monitoring: We provide regular follow-up appointments to track your progress, address concerns, and optimize your treatment plan
Semaglutide, by contrast, activates GLP-1 receptors in your brain and pancreas, increasing insulin release when blood sugar rises and slowing stomach emptying to reduce hunger signals
Insurance or EHR printouts showing continuity of use, especially if you tried multiple GLP-1 brands
GLP-1 RA medications are grouped into 2 categories (long and short-acting RA) [1] Long-acting RA: Provides longer GLP-1 receptor activation